Halliburton Announces Third Quarter 2026 Results

Halliburton reported Q3 2026 net income attributable to the company of $417 million, or $0.50 per diluted share, down from $534 million, or $0.64, in Q2 2026. Q3 adjusted net income, excluding impairments, other charges and tax adjustments, was $501 million, or $0.60 per diluted share; the provided excerpt gives no Q2 adjusted comparison.

Analysis

The sequential decline in reported earnings is a caution signal, but the excerpt does not provide adjusted Q2 EPS, revenue, segment results, guidance, cash flow, or consensus estimates. It therefore cannot establish whether underlying performance deteriorated, whether HAL missed expectations, or whether the quarter changes the forward earnings path. The $84 million gap between reported and adjusted Q3 net income makes the nature and recurrence of excluded charges decision-relevant: recurring “one-time” costs would weaken the case for treating adjusted earnings as the right run rate.

For the next few sessions, the key risk is an earnings reaction driven by missing details rather than the headline EPS comparison. Over 1–3 months, watch management’s activity and pricing commentary, segment margins, and cash conversion for evidence that weaker customer spending or utilization is flowing through results. If the softness is concentrated in one region or business line, competitors such as SLB and Baker Hughes may have different exposures; this excerpt is insufficient to infer relative winners. Over 6–18 months, sustained customer budget restraint would pressure service pricing and utilization, while resilient activity and cash generation could make the reported decline a poor guide to normalized earnings.

Contrarian read: the headline may overstate deterioration if excluded charges are nonrecurring, but adjusted EPS alone is not proof of resilience. No directional or pair trade is warranted from this partial release; seek the full filing and call before taking a view.

Key Decisions for Investors

• Do not trade the quarter on the headline EPS comparison alone; obtain the complete release and reconcile reported-to-adjusted earnings, including the type and recurrence of excluded charges.
• Before adding to HAL, verify revenue and margin trends by segment, forward activity/pricing guidance, free cash flow, and any change in capital-return plans; these are the missing inputs that would establish earnings durability.
• Treat a sustained cut to activity or pricing guidance, deteriorating segment margins, or weaker cash conversion as thesis-falsifying evidence for a recovery view; resilient guidance and cash generation would weaken the bearish read.
• Monitor HAL’s post-release price action and peer commentary from SLB and Baker Hughes over the coming weeks, but avoid a relative-value position until comparable segment exposure and results are available.